Pills morph as patients try to cope
Later this year, when the popular statin Lipitor becomes available as a generic drug, many who have taken it faithfully will get a surprise. No longer will their cholesterol-lowering pills be oblong and white. If they choose a generic alternative, their pills will be anything but that color and shape, and their appearance may change from refill to refill as pharmacists switch among generic competitors. The result may well be confusion among patients, who often take multiple drugs and have trouble keeping track of them if their shapes and colors change all the time, two researchers at Harvard University say. With generics accounting for 70% of all drugs on the market, the seldom-discussed issue of their ever-changing appearances affects almost anyone who fills a prescription.
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- Carondelet to Pay $35M to Settle Fraud Allegations
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- CA Powers Up $80M HIE to 'Create Value in the Data'
- 3 Traits Personality Assessments Can't Reveal